» Articles » PMID: 1970323

Mechanism of Gamma-glutamyl Transpeptidase Release in Serum During Intrahepatic and Extrahepatic Cholestasis in the Rat: a Histochemical, Biochemical and Molecular Approach

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1990 Apr 1
PMID 1970323
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of the elevation of serum gamma-glutamyl transpeptidase activity in cholestasis is not clear. We therefore analyzed rat gamma-glutamyl transpeptidase activities in liver, bile and serum during intrahepatic cholestasis induced by a single dose of alpha-naphthyl isothiocyanate (20 mg/100 gm body weight) and during extrahepatic cholestasis after bile duct ligation. At days 1 and 2 after alpha-naphthyl isothiocyanate ingestion, we saw a fivefold and a 60-fold increase in serum and bile gamma-glutamyl transpeptidase activities, respectively. These increases were associated with a decrease in hepatic gamma-glutamyl transpeptidase activity and of corresponding mRNA. Simultaneously, necrosis of the biliary epithelium appeared in portal tracts. From day 2 to day 14, gamma-glutamyl transpeptidase activity in bile and serum progressively returned to basal levels; in the liver, cholangiolar proliferation was mild and was associated with moderate elevation of the gamma-glutamyl transpeptidase activity and of its corresponding mRNA. In extrahepatic cholestasis, a 10-fold increase in serum gamma-glutamyl transpeptidase activity was detected between day 0 and day 14. This increase was associated with major cholangiolar proliferation and with a progressive rise in hepatic gamma-glutamyl transpeptidase activity and in specific mRNA; in bile, gamma-glutamyl transpeptidase activity was slightly elevated. In these two models of cholestasis, histochemically detected gamma-glutamyl transpeptidase activity was largely predominant in biliary cells. We found no significant induction of gamma-glutamyl transpeptidase activity in hepatocytes. These results suggest that in these two models of cholestasis, the increase in serum gamma-glutamyl transpeptidase activity is of biliary cell origin and does not originate from hepatocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

(Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study.

Shetty M, Shenoy S, Amuthan A, Devi V, Kumar N, Kiran A F1000Res. 2025; 13:639.

PMID: 39916986 PMC: 11800331. DOI: 10.12688/f1000research.145961.2.


Extrahepatic biliary atresia and normal-range serum gamma-glutamyltranspeptidase activity: A case report.

Kohlmaier B, Tichy H, Blatterer J, Till H, Schlagenhauf A, Knisely A JPGN Rep. 2024; 5(4):533-537.

PMID: 39610416 PMC: 11600354. DOI: 10.1002/jpr3.12131.


Chemopreventive potential of goniothalamin in diethylnitrosamine-induced hepatocellular carcinoma through the suppression of P13K/AKT signalling pathway.

Li J, Zhan D, Chen C, Li R, Zhu F Korean J Physiol Pharmacol. 2024; 28(6):539-547.

PMID: 39467717 PMC: 11519720. DOI: 10.4196/kjpp.2024.28.6.539.


Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis.

Wang C, Qin Z, Zhang M, Dai Y, Zhang L, Tian W J Transl Autoimmun. 2024; 8:100239.

PMID: 38550612 PMC: 10973586. DOI: 10.1016/j.jtauto.2024.100239.


Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH.

Cabibi D, Giannone A, Quattrocchi A, Calvaruso V, Porcasi R, Di Grusa D Biomedicines. 2024; 12(2).

PMID: 38398042 PMC: 10887071. DOI: 10.3390/biomedicines12020440.